Your browser doesn't support javascript.
loading
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Hewison, Catherine; Khan, Uzma; Bastard, Mathieu; Lachenal, Nathalie; Coutisson, Sylvine; Osso, Elna; Ahmed, Saman; Khan, Palwasha; Franke, Molly F; Rich, Michael L; Varaine, Francis; Melikyan, Nara; Seung, Kwonjune J; Adenov, Malik; Adnan, Sana; Danielyan, Narine; Islam, Shirajul; Janmohamed, Aleeza; Karakozian, Hayk; Kamene Kimenye, Maureen; Kirakosyan, Ohanna; Kholikulov, Begimkul; Krisnanda, Aga; Kumsa, Andargachew; Leblanc, Garmaly; Lecca, Leonid; Nkuebe, Mpiti; Mamsa, Shahid; Padayachee, Shrivani; Thit, Phone; Mitnick, Carole D; Huerga, Helena.
  • Hewison C; Medical Department, Médecins Sans Frontières, Paris, France.
  • Khan U; Interactive Research and Development Global, Singapore, Singapore.
  • Bastard M; Field Epidemiology Department, Epicentre, Paris, France.
  • Lachenal N; Pharmacovigilance Unit, Médecins Sans Frontières, Geneva, Switzerland.
  • Coutisson S; Pharmacovigilance Unit, Médecins Sans Frontières, Geneva, Switzerland.
  • Osso E; Partners In Health, Boston, Massachusetts, USA, and Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Ahmed S; Interactive Research and Development, Karachi, Pakistan.
  • Khan P; Interactive Research and Development Global, Singapore, Singapore.
  • Franke MF; Partners In Health, Boston, Massachusetts, USA, and Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Rich ML; Partners In Health, Boston, Massachusetts, USA, and Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Varaine F; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Melikyan N; Medical Department, Médecins Sans Frontières, Paris, France.
  • Seung KJ; Field Epidemiology Department, Epicentre, Paris, France.
  • Adenov M; Partners In Health, Boston, Massachusetts, USA, and Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Adnan S; Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Danielyan N; National Scientific Center of Phthisiopulmonology, MOH RK (NSCP MOH RK), Almaty, Kazakhstan.
  • Islam S; Indus Health Network, Karachi, Pakistan.
  • Janmohamed A; Medical Department, Médecins Sans Frontières, Tbilisi, Georgia.
  • Karakozian H; Interactive Research and Development, Dhaka, Bangladesh.
  • Kamene Kimenye M; Interactive Research and Development, Karachi, Pakistan.
  • Kirakosyan O; Medical Department, Médecins Sans Frontières, Bishkek, Krygystan.
  • Kholikulov B; National Tuberculosis Program, Nairobi, Kenya.
  • Krisnanda A; Medical Department, Médecins Sans Frontières, Yerevan, Armenia.
  • Kumsa A; Medical Department, Médecins Sans Frontières, Minsk, Belarus.
  • Leblanc G; Aga Krisnanda, Interactive Research and Development, Jakarta, Indonesia.
  • Lecca L; Partners In Health, Addis Ababa, Ethiopia.
  • Nkuebe M; Zanmi Lasante, Cange, Haiti.
  • Mamsa S; Socios En Salud Sucursal Peru, Lima, Peru.
  • Padayachee S; Partners In Health, Maseru, Lesotho.
  • Thit P; Indus Health Network, Karachi, Pakistan.
  • Mitnick CD; Interactive Research and Development, Durban, South Africa.
  • Huerga H; Medical Department, Médecins Sans Frontières, Yangon, Myanmar.
Clin Infect Dis ; 75(6): 1006-1013, 2022 09 29.
Article en En | MEDLINE | ID: mdl-35028659

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Nitroimidazoles Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis Resistente a Múltiples Medicamentos / Nitroimidazoles Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article